Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]

DRUG2 trials

Sponsors

State University of New York at Buffalo, Fundacion SEIMC-GESIDA

Conditions

HIV InfectionsHIV-1-infection

Phase 4

Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED)

CompletedNCT05405751

Fundacion SEIMC-GESIDAHIV Infections

Start: 2022-07-04End: 2024-06-12Updated: 2026-06-30

Unknown Phase

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruitingNCT05064020

State University of New York at BuffaloHIV-1-infection

Start: 2020-08-01End: 2024-12-31Target: 162Updated: 2024-06-04